Ulrich H W Beuers

18PUBLICATIONS
77CO-AUTHORS
Predictive and prognostic markersEthical use of new technologyCancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - carbohydratesChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Apr 13, 2026
Fracture risk under selective and non-selective PPAR agonists in primary biliary cholangitis.

Ulrich Beuers, Alexandra Rousseau, Stan F J van de Graaf

|Feb 19, 2026
Reply to 'The ethics of unlicensed therapy use in primary biliary cholangitis: a counter view'.

Christophe Corpechot, Maria-Carlota Londoño, Alejandra Villamil

|Dec 09, 2025
Effectiveness and tolerability of bezafibrate in primary biliary cholangitis - a nationwide real-world study.

Maria C van Hooff, Rozanne C de Veer, Ellen Werner

|Oct 10, 2025
Bezafibrate for primary biliary cholangitis: time to act on the evidence.

Christophe Corpechot, Maria-Carlota Londoño, Alejandra Villamil

|Mar 20, 2024
Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?

David E J Jones, Ulrich Beuers, Alan Bonder

|Feb 19, 2024
PPARα, PPARδ, or both-that is the question!

Frank Wolters, Ronald P J Oude Elferink, Ulrich Beuers

Pageof 3

Frequent Collaborators

4 joint publications

Kim N van Munster

4 joint publications

Cyriel Y Ponsioen

3 joint publications

Christophe Corpechot

3 joint publications

Atsushi Tanaka